2014
DOI: 10.1007/s12105-014-0555-3
|View full text |Cite
|
Sign up to set email alerts
|

Malignant Rhabdoid Tumor of the Floor of Mouth: First Reported Case in the Oral Cavity of an Adult

Abstract: Malignant rhabdoid tumors (MRTs) are exceedingly rare lesions. To our knowledge, only 2 cases have been reported in the oral cavity, with both examples occurring in infants. The current case is the third reported case of MRT of the oral cavity and the first reported case to occur in an adult at this location. The following report describes the clinical, histologic and immunohistochemical features of this tumor.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 24 publications
0
1
0
Order By: Relevance
“…Finally, our study for the first time in some details describes adult-onset RT. Although the presence of rhabdoid features is frequently depicted in various malignancies, genuine extra-cranial RT are very rarely reported in adults [ 24 29 ], raising some doubts about diagnostic accuracy in such cases. In our hands, not all of the presumed adult RT are confirmed to be true “molecular” RT; such a distinction should have clinical implication, especially for the interpretation of adults phase I-II trials that aim to target RT vulnerability defined on pediatric tumors.…”
Section: Discussionmentioning
confidence: 99%
“…Finally, our study for the first time in some details describes adult-onset RT. Although the presence of rhabdoid features is frequently depicted in various malignancies, genuine extra-cranial RT are very rarely reported in adults [ 24 29 ], raising some doubts about diagnostic accuracy in such cases. In our hands, not all of the presumed adult RT are confirmed to be true “molecular” RT; such a distinction should have clinical implication, especially for the interpretation of adults phase I-II trials that aim to target RT vulnerability defined on pediatric tumors.…”
Section: Discussionmentioning
confidence: 99%